CROCS INC (CROX)

US2270461096 - Common Stock

155.64  -0.33 (-0.21%)

After market: 156.869 +1.23 (+0.79%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CROX. CROX was compared to 51 industry peers in the Textiles, Apparel & Luxury Goods industry. CROX has an excellent profitability rating, but there are some minor concerns on its financial health. CROX is not valued too expensively and it also shows a decent growth rate.



9

1. Profitability

1.1 Basic Checks

In the past year CROX was profitable.
CROX had a positive operating cash flow in the past year.
CROX had positive earnings in each of the past 5 years.
Each year in the past 5 years CROX had a positive operating cash flow.

1.2 Ratios

With an excellent Return On Assets value of 16.59%, CROX belongs to the best of the industry, outperforming 96.00% of the companies in the same industry.
CROX has a Return On Equity of 49.81%. This is amongst the best in the industry. CROX outperforms 96.00% of its industry peers.
With an excellent Return On Invested Capital value of 21.10%, CROX belongs to the best of the industry, outperforming 96.00% of the companies in the same industry.
CROX had an Average Return On Invested Capital over the past 3 years of 30.08%. This is significantly above the industry average of 10.54%.
The last Return On Invested Capital (21.10%) for CROX is well below the 3 year average (30.08%), which needs to be investigated, but indicates that CROX had better years and this may not be a problem.
Industry RankSector Rank
ROA 16.59%
ROE 49.81%
ROIC 21.1%
ROA(3y)25.34%
ROA(5y)24.04%
ROE(3y)1755.79%
ROE(5y)1093.13%
ROIC(3y)30.08%
ROIC(5y)27.47%

1.3 Margins

With an excellent Profit Margin value of 19.80%, CROX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CROX's Profit Margin has declined in the last couple of years.
CROX's Operating Margin of 26.43% is amongst the best of the industry. CROX outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of CROX has grown nicely.
The Gross Margin of CROX (56.16%) is better than 72.00% of its industry peers.
In the last couple of years the Gross Margin of CROX has grown nicely.
Industry RankSector Rank
OM 26.43%
PM (TTM) 19.8%
GM 56.16%
OM growth 3Y13.61%
OM growth 5Y32.68%
PM growth 3Y-3.95%
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5Y1.62%

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CROX is creating value.
CROX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CROX has been reduced compared to 5 years ago.
Compared to 1 year ago, CROX has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 4.27 indicates that CROX is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.27, CROX is doing good in the industry, outperforming 72.00% of the companies in the same industry.
CROX has a debt to FCF ratio of 2.19. This is a good value and a sign of high solvency as CROX would need 2.19 years to pay back of all of its debts.
CROX has a Debt to FCF ratio (2.19) which is in line with its industry peers.
A Debt/Equity ratio of 1.08 is on the high side and indicates that CROX has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.08, CROX is doing worse than 82.00% of the companies in the same industry.
Although CROX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 2.19
Altman-Z 4.27
ROIC/WACC2.21
WACC9.56%

2.3 Liquidity

CROX has a Current Ratio of 1.76. This is a normal value and indicates that CROX is financially healthy and should not expect problems in meeting its short term obligations.
CROX's Current ratio of 1.76 is on the low side compared to the rest of the industry. CROX is outperformed by 66.00% of its industry peers.
CROX has a Quick Ratio of 1.14. This is a normal value and indicates that CROX is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CROX (1.14) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.14

6

3. Growth

3.1 Past

CROX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.46%, which is quite good.
CROX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 55.01% yearly.
CROX shows a small growth in Revenue. In the last year, the Revenue has grown by 6.29%.
CROX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.49% yearly.
EPS 1Y (TTM)8.46%
EPS 3Y55.01%
EPS 5YN/A
EPS Q2Q%15.71%
Revenue 1Y (TTM)6.29%
Revenue growth 3Y41.93%
Revenue growth 5Y29.49%
Sales Q2Q%6.16%

3.2 Future

CROX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.49% yearly.
The Revenue is expected to grow by 7.26% on average over the next years.
EPS Next Y7.19%
EPS Next 2Y8.07%
EPS Next 3Y7.71%
EPS Next 5Y8.49%
Revenue Next Year4.46%
Revenue Next 2Y5.07%
Revenue Next 3Y4.19%
Revenue Next 5Y7.26%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.51 indicates a correct valuation of CROX.
Based on the Price/Earnings ratio, CROX is valued a bit cheaper than 80.00% of the companies in the same industry.
CROX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.05.
Based on the Price/Forward Earnings ratio of 11.08, the valuation of CROX can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CROX indicates a rather cheap valuation: CROX is cheaper than 82.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.07, CROX is valued a bit cheaper.
Industry RankSector Rank
PE 12.51
Fwd PE 11.08

4.2 Price Multiples

CROX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CROX is cheaper than 62.00% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as CROX.
Industry RankSector Rank
P/FCF 11.97
EV/EBITDA 9.86

4.3 Compensation for Growth

CROX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CROX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.74
PEG (5Y)N/A
EPS Next 2Y8.07%
EPS Next 3Y7.71%

0

5. Dividend

5.1 Amount

CROX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

NASDAQ:CROX (5/31/2024, 7:00:00 PM)

After market: 156.869 +1.23 (+0.79%)

155.64

-0.33 (-0.21%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap9.45B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 12.51
Fwd PE 11.08
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.74
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.59%
ROE 49.81%
ROCE
ROIC
ROICexc
ROICexgc
OM 26.43%
PM (TTM) 19.8%
GM 56.16%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.76
Quick Ratio 1.14
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)8.46%
EPS 3Y55.01%
EPS 5Y
EPS Q2Q%
EPS Next Y7.19%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)6.29%
Revenue growth 3Y41.93%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y